ANG Lifesciences

{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "24.99",
    "chg": 1.03,
    "chgp": "4.3%",
    "dir": 1,
    "prev_price": "23.96",
    "mcapval": "33.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE236W01016",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "684 ",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3771074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ANGLifesciences_mojoScore_3771074.png",
        "date": "2025-12-26 15:13:06",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "ANG Lifesciences Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3750662",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ANGLifesciences_mojoScore_3750662.png",
        "date": "2025-12-08 10:10:22",
        "description": "ANG Lifesciences has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The pharmaceutical and biotechnology company’s recent assessment highlights concerns across multiple parameters, signalling a cautious outlook for investors amid persistent underperformance and financial strain."
      },
      {
        "title": "ANG Lifesciences India Surges with Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3737724",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ANGLifesciences_only_buyers_3737724.png",
        "date": "2025-12-01 09:31:18",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The stock’s performance today stands out sharply against the broader market, reflecting a rare scenario of sustained demand and no selling pressure, potentially signalling a multi-day circuit phenomenon."
      },
      {
        "title": "Why is ANG Lifesciences falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ang-lifesciences-fallingrising-3736244",
        "imagepath": "",
        "date": "2025-11-29 01:02:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>ANG Lifesciences has recorded a consecutive three-day rally, accumulating a 15.67% return during this period. Today's session opened with a gap up of 4.95%, signalling strong buying interest at the outset. The stock outperformed its sector by 4.44% today, indicating relative strength compared to its peers. Intraday, the price fluctuated between a low of ₹25.70 and a high of ₹27.98, ultimately settling at the day's peak level.</p>\n<p>Despite this recent upswing, the stock's longer-term performance remains subdued. Year-to-date, ANG Lifesciences has declined by 37.39%, contrasting sharply with the Sensex's 9.68% gain over the same period. Over one year, the stock is down 37.82%, while the Sensex has advanced 8.43%. The three-year tre..."
      },
      {
        "title": "ANG Lifesciences India Sees Unprecedented Buying Interest Amid Upper Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3735403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3735403.png",
        "date": "2025-11-28 10:20:36",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike."
      },
      {
        "title": "ANG Lifesciences India Sees Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3732947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3732947.png",
        "date": "2025-11-27 09:41:34",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "ANG Lifesciences India Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3731342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3731342.png",
        "date": "2025-11-26 11:45:33",
        "description": "ANG Lifesciences India has witnessed a remarkable surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market behaviour signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike."
      },
      {
        "title": "ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-faces-severe-selling-pressure-amid-prolonged-downtrend-3728379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_sellers_3728379.png",
        "date": "2025-11-25 10:20:55",
        "description": "ANG Lifesciences India is experiencing severe selling pressure, with the stock registering a sharp decline of 4.99% today and no buyers visible in the order book. This marks the seventh consecutive day of losses, reflecting a sustained period of distress selling that has significantly impacted the stock’s performance across multiple time frames."
      },
      {
        "title": "ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-faces-severe-selling-pressure-amid-prolonged-downtrend-3724294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_sellers_3724294.png",
        "date": "2025-11-24 09:55:48",
        "description": "ANG Lifesciences India is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the order book. The pharmaceutical and biotechnology company has seen a continuous decline over the past week, signalling distress selling and heightened market caution."
      }
    ],
    "total": 284,
    "sid": "1002820",
    "stock_news_url": "https://www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "22-Jan-2026",
      "details": "Disclosure under Reg. 74(5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "22-Dec-2025",
      "details": "Closure of Trading Window.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025",
      "datetime": "14-Nov-2025",
      "details": "Unaudited Financial Results for the Quarter and Half year ended 30.09.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

ANG Lifesciences India Ltd is Rated Strong Sell

2025-12-26 15:13:06

ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.

Read full news article

ANG Lifesciences Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-08 10:10:22

ANG Lifesciences has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The pharmaceutical and biotechnology company’s recent assessment highlights concerns across multiple parameters, signalling a cautious outlook for investors amid persistent underperformance and financial strain.

Read full news article

ANG Lifesciences India Surges with Unprecedented Buying Interest, Hits Upper Circuit

2025-12-01 09:31:18

ANG Lifesciences India has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The stock’s performance today stands out sharply against the broader market, reflecting a rare scenario of sustained demand and no selling pressure, potentially signalling a multi-day circuit phenomenon.

Read full news article

Why is ANG Lifesciences falling/rising?

2025-11-29 01:02:50

Short-Term Price Movement and Market Context

ANG Lifesciences has recorded a consecutive three-day rally, accumulating a 15.67% return during this period. Today's session opened with a gap up of 4.95%, signalling strong buying interest at the outset. The stock outperformed its sector by 4.44% today, indicating relative strength compared to its peers. Intraday, the price fluctuated between a low of ₹25.70 and a high of ₹27.98, ultimately settling at the day's peak level.

Despite this recent upswing, the stock's longer-term performance remains subdued. Year-to-date, ANG Lifesciences has declined by 37.39%, contrasting sharply with the Sensex's 9.68% gain over the same period. Over one year, the stock is down 37.82%, while the Sensex has advanced 8.43%. The three-year tre...

Read full news article

ANG Lifesciences India Sees Unprecedented Buying Interest Amid Upper Circuit Lock

2025-11-28 10:20:36

ANG Lifesciences India has witnessed extraordinary buying momentum, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike.

Read full news article

ANG Lifesciences India Sees Unprecedented Buying Interest, Hits Upper Circuit

2025-11-27 09:41:34

ANG Lifesciences India has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector.

Read full news article

ANG Lifesciences India Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

2025-11-26 11:45:33

ANG Lifesciences India has witnessed a remarkable surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market behaviour signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike.

Read full news article

ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 10:20:55

ANG Lifesciences India is experiencing severe selling pressure, with the stock registering a sharp decline of 4.99% today and no buyers visible in the order book. This marks the seventh consecutive day of losses, reflecting a sustained period of distress selling that has significantly impacted the stock’s performance across multiple time frames.

Read full news article

ANG Lifesciences India Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 09:55:48

ANG Lifesciences India is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the order book. The pharmaceutical and biotechnology company has seen a continuous decline over the past week, signalling distress selling and heightened market caution.

Read full news article

View All News